Company research
MEDICAL EXERCISE INC.
CIK 2001249
Filing activity
Latest filing
8 filings on record · 10-Q, NT 10-Q, 10-K, D, D/A, 8-K/A.
Recent filings
Show 3 more recent filings
Financials
FY 2026 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2026 | FY 2025 |
|---|---|---|
| ASSETS | ||
| AssetsUSD | 61,330Source | 65,261Source |
| Property, Plant and Equipment, NetUSD | 15,924Source | 59,903Source |
| Current assets: | ||
| Cash and Cash Equivalents, at Carrying ValueUSD | 43,449Source | 450Source |
| Assets, CurrentUSD | 43,449Source | 450Source |
| LIABILITIES AND EQUITY | ||
| Stockholders’ equity: | ||
| Common Stock, Value, IssuedUSD | 522,700Source | 412,200Source |
| Retained Earnings (Accumulated Deficit)USD | -705,707Source | -478,999Source |
| Stockholders' Equity Attributable to ParentUSD | -183,507Source | -67,299Source |
| Liabilities and EquityUSD | 61,330Source | 65,261Source |
| Current liabilities: | ||
| Liabilities, CurrentUSD | 244,837Source | 132,560Source |
cash flow · annual statements
| Line item | FY 2026 | FY 2025 |
|---|---|---|
| Cash flows from operating activities: | ||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation, Depletion and AmortizationUSD | 8,736Source | 11,492Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 2,000Source | 100,000Source |
| Deferred Income Tax Expense (Benefit)USD | 66,514Source | -83,668Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -194,751Source | -191,027Source |
| Cash flows from investing activities: | ||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 33,849Source | -5,685Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | 3,869Source |
| Cash flows from financing activities: | ||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 203,901Source | 186,505Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 43,449Source | 450Source |
| Additional Financial Items | ||
| AmortizationUSD | — | 2,122Source |
| Amortization of Intangible AssetsUSD | 2,758Source | — |
| DepreciationUSD | 5,978Source | 9,370Source |
| Gain (Loss) on Disposition of Intangible AssetsUSD | -2,550Source | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | -1,795Source | 389Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | -331,374Source |
| Net Income (Loss) Attributable to ParentUSD | -226,708Source | -330,985Source |
| Nonoperating Income (Expense)USD | -4,345Source | 389Source |
| Operating ExpensesUSD | 222,363Source | 332,223Source |
| Other Depreciation and AmortizationUSD | 8,735Source | — |
| Proceeds from Issuance of Common StockUSD | 108,500Source | 15,500Source |
income statement · annual statements
| Line item | FY 2026 | FY 2025 |
|---|---|---|
| Total RevenueUSD | — | 1,294Source |
| Cost of Goods and Services Sold | — | — |
| Gross Profit (Calculated) · Derived | — | — |
| Selling, General and Administrative ExpenseUSD | — | 176,271Source |
| Operating Income (Loss)USD | -222,363Source | 849Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -226,708Source | -330,985Source |
| Net Income (Loss) Attributable to ParentUSD | -226,708Source | -330,985Source |
| Earnings Per Share, BasicUSD per share | -0.02Source | -0.03Source |
| Earnings Per Share, DilutedUSD per share | -0.02Source | -0.03Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 12,599,986Source | 12,187,151Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 12,599,986Source | 12,187,151Source |
| Additional Financial Items | ||
| Amortization of Intangible AssetsUSD | 2,758Source | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | -331,374Source |
| Nonoperating Income (Expense)USD | -4,345Source | 389Source |
| Operating ExpensesUSD | 222,363Source | 332,223Source |